about
Immunosuppressive treatment for idiopathic membranous nephropathy in adults with nephrotic syndromeAlternative Pathway Dysregulation and the Conundrum of Complement Activation by IgG4 Immune Complexes in Membranous NephropathyMembranous nephropathy: not just a disease for adultsACTH (Acthar Gel) Reduces Toxic SOD1 Protein Linked to Amyotrophic Lateral Sclerosis in Transgenic Mice: A Novel ObservationPhospholipase A2 receptor autoantibodies and clinical outcome in patients with primary membranous nephropathyMembranous nephropathy: from models to manThe calcineurin inhibitor tacrolimus reduces proteinuria in membranous nephropathy accompanied by a decrease in angiopoietin-like-4.Evaluating tacrolimus treatment in idiopathic membranous nephropathy in a cohort of 408 patients.Immunosuppression for membranous nephropathy: a systematic review and meta-analysis of 36 clinical trialsTreatment with rituximab in idiopathic membranous nephropathy.The Influence and Role of Microbial Factors in Autoimmune Kidney Diseases: A Systematic Review.Membranous glomerulonephritis: histological and serological features to differentiate cancer-related and non-related forms.Renal Phospholipase A2 Receptor and the Clinical Features of Idiopathic Membranous Nephropathy.Two cases of idiopathic membranous nephropathy treated with rituximab.Long-term outcomes of persistent disease and relapse in primary membranous nephropathy.Role of anti-phospholipase A(2) receptor antibodies in the differential diagnosis of diabetic and membranous nephropathy.Scavengers of reactive oxygen species, paracalcitol, RhoA, and Rac-1 inhibitors and tacrolimus inhibit angiotensin II-induced actions on glomerular permeability.Mortality and renal outcome of primary glomerulonephritis in Korea: observation in 1,943 biopsied cases.A case report of remission of refractory membranous nephropathy progressing to stage 4 chronic kidney disease using low-dose rituximab: A long-term follow-up.Role of Tacrolimus only therapy in modified Ponticelli regimen resistant idiopathic membranous glomerulonephritis
P2860
Q24193098-85B4783A-E19F-447D-810F-5683D1934490Q26747416-316B3B22-91ED-47A4-899D-93AC8A0B9FCDQ26866206-2F0FCA90-CC4B-4399-853F-59E780912DFEQ28547127-7FFBEA17-0197-4259-85A9-4CBEB7F8502AQ33660542-63DB4D6E-4D24-49DF-975A-7D072CA45861Q33872569-1B314DC3-86F7-4948-9E4A-D324273C22A0Q34105415-C108EEC6-1E50-454A-95C0-56E6970668CEQ36240947-ACB133E0-6E92-4D20-9C47-19E2D3B03462Q36810470-C053E6CD-CBB8-42BD-BD2C-B394828AC876Q37511019-68BE50DD-28E6-42EF-A10A-8EBF21CE603BQ38528984-0096DE25-F9D4-4FFB-83C8-A7AF0EDBA75DQ38711526-DA58551B-E1FB-4B64-B3B7-7836ED2E29A1Q38842914-D1525D92-87D8-415C-BFBE-2D2D0D18A85CQ39996521-EFD2938C-A536-4882-B697-925776B0FC9EQ40105860-6661CA57-26CB-4485-925E-7276C3C679B0Q43087627-10A780B9-3975-47D1-9E9D-234CC6510E38Q45746271-0CD5B5F5-1BE0-466D-86D6-4A46D9F8EAFFQ46343722-E318E9AE-D6CE-4736-9821-7CF8E5E65B78Q55434137-D4954240-2262-49FC-9C80-37830AB20EBBQ57370957-AFB99B8F-2F16-4ACB-9DE7-72E568EBCC0E
P2860
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Treatment of idiopathic membranous nephropathy.
@ast
Treatment of idiopathic membranous nephropathy.
@en
type
label
Treatment of idiopathic membranous nephropathy.
@ast
Treatment of idiopathic membranous nephropathy.
@en
prefLabel
Treatment of idiopathic membranous nephropathy.
@ast
Treatment of idiopathic membranous nephropathy.
@en
P2860
P356
P1476
Treatment of idiopathic membranous nephropathy.
@en
P2093
Howard A Austin
Meryl Waldman
P2860
P304
P356
10.1681/ASN.2012010058
P577
2012-08-02T00:00:00Z